Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 391 | 400 | 1,280 | 7,420 | 7,330 |
| Marketable Securities | 1,217 | 1,060 | 0 | 0 | 0 |
| Receivables | N/A | 0 | 1,110 | 0 | 1 |
| Other current assets | 0 | 180 | 190 | 0 | -1 |
| TOTAL | $1,799 | $1,640 | $2,580 | $7,420 | $7,330 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 830 | 0 | 0 |
| Investments And Advances | 6 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 100 | 390 | 1,340 | 40 | 8 |
| TOTAL | $105 | $390 | $2,170 | $40 | $8 |
| Total Assets | $1,904 | $2,040 | $4,770 | $7,460 | $7,340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 487 | 320 | 700 | 0 | 0 |
| Accrued Expenses | N/A | 0 | 0 | 30 | 4 |
| Other current liabilities | N/A | 130 | 660 | 0 | 0 |
| TOTAL | $561 | $450 | $1,370 | $80 | $80 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 40 | 7,370 | 7,260 |
| TOTAL | $N/A | $N/A | $40 | $7,370 | $7,260 |
| Total Liabilities | $561 | $450 | $1,410 | $7,460 | $7,340 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 1 | 0 | 0 |
| Retained earnings | -2,958 | -2,850 | -1,850 | 0 | 0 |
| Other shareholders' equity | -108 | -90 | -401 | 0 | 0 |
| TOTAL | $1,344 | $1,580 | $3,350 | $0 | $0 |
| Total Liabilities And Equity | $1,904 | $2,030 | $4,760 | $7,460 | $7,340 |